Atlas Trials

A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)

Clinical trial NCT00209261 · COMPLETED

Trial details

NCT number
NCT00209261
Sponsor
Ferring Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Primary Nocturnal Enuresis
Start date
2004-12-01
Primary completion
2005-08-01
Enrollment
221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.